BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 78 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $331,000 | -7.3% | 7,629 | -0.6% | 0.02% | -8.3% |
| Q3 2017 | $357,000 | -9.2% | 7,674 | -3.4% | 0.02% | -11.1% |
| Q2 2017 | $393,000 | -66.4% | 7,946 | -62.8% | 0.03% | -66.7% |
| Q1 2017 | $1,171,000 | -99.9% | 21,368 | 0.0% | 0.08% | -37.7% |
| Q4 2016 | $1,190,000,000 | – | 21,368 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 211,370 | $9,833,000 | 5.80% |
| JW Asset Management, LLC | 73,649 | $3,426,000 | 2.51% |
| NORTHPOINTE CAPITAL LLC | 135,657 | $6,311,000 | 0.67% |
| Elk Creek Partners, LLC | 170,102 | $7,913,000 | 0.50% |
| RICE HALL JAMES & ASSOCIATES, LLC | 156,167 | $7,265,000 | 0.32% |
| Ativo Capital Management LLC | 22,592 | $1,051,000 | 0.28% |
| Matarin Capital Management, LLC | 59,077 | $2,748,262,000 | 0.23% |
| ISTHMUS PARTNERS, LLC | 16,753 | $779,000 | 0.22% |
| CADENCE CAPITAL MANAGEMENT LLC | 29,586 | $1,376,000 | 0.09% |
| ALGERT GLOBAL LLC | 7,834 | $364,000 | 0.08% |